Saama Technologies, a Carlyle Portfolio Company, specializes in addressing the unique needs of pharmaceutical and biotech companies by delivering transformative business outcomes. With a strong focus on AI research, advanced technical and analytics capabilities, and deep domain expertise across the drug development and commercialization lifecycle, Saama has established itself as a trusted partner and thought leader in the life sciences industry. The company emphasizes a collaborative approach to product co-development, aiming to enhance customer success and drive innovation in the sector.